|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock compensation expense | |||||
| Deferred income taxes | |||||
| (Recovery of) provision for credit losses | |||||
| Asset impairment charge | |||||
| Unrealized gain on foreign currency transactions and deferred compensation | |||||
| Asset impairment charge and (gain) loss on disposal of assets | |||||
| Change in fair value of contingent consideration liability | |||||
| Changes in assets and liabilities, net of acquired balances | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Income taxes | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures and intangible assets acquired | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Proceeds from sale of assets | |||||
| Proceeds from settlement of net investment hedge | |||||
| Proceeds from insurance | |||||
| Investment in affiliates | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from revolving loan | |||||
| Principal payments on revolving debt | |||||
| Principal payments on acquired debt | |||||
| Cash paid for financing costs | |||||
| Principal payments on finance lease | |||||
| Proceeds from stock options exercised | |||||
| Dividends paid | |||||
| Repurchases of common stock | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents beginning of period | |||||
| Cash and cash equivalents end of period | |||||
Loading...